Zenith Technologies appoints MES lead
James O’Brien will lead the company's manufacturing execution system business to its next phase of growth.
Global life science technology firm, Zenith Technologies, has appointed James O’Brien to lead its manufacturing execution system (MES) business to its next phase of growth.
During the past 5 years, Zenith Technologies has strategically grown its MES offering globally to meet growing demand for technology-based manufacturing efficiency programs in the life science sector.
In his role as MES business unit lead, James will use his background in software development, consultancy and technology implementation to continue to develop Zenith Technologies as a world leader in the provision of MES solutions and services to the life science industry.
Zenith Technologies assists pharmaceutical and medical device manufacturers with the implementation of MES solutions, providing on-the-ground support. James will be focused on forming further collaborations in the industry to support life science companies with the transition to MES and automated systems.
Commenting on the appointment, Jim Lehane, director at Zenith Technologies, said: “James has worked with us as a senior MES engineer for a number of years, supporting some of the world’s leading pharmaceutical companies with global automation projects. In his new role as MES business unit lead, James will drive Zenith Technologies forward to further success in the US and Europe, leveraging our global presence, skilled engineers and world-class implementation and support services.”
James’ appointment comes as MES technology is being adopted by the life science industry at a faster rate than any other vertical market. To support demand, the firm recently announced a partnership with MES software provider Werum IT Solutions.
Jim continued: “It’s an exciting time for our company, as pharmaceutical and medical device manufacturers are recognising the benefits of MES and adoption is increasing at a steady rate. In particular, we are experiencing increasing demand in the US market, which has led us to open two new offices in Oakland and San Diego.”
Based in Bluebell, PA, James will lead Zenith Technologies’ team of engineers in 16 offices globally to support clients with their manufacturing enterprise solution needs.
He said: “MES technology can dramatically improve productivity during manufacturing, however there are a number of challenges associated with its implementation. It is our goal to assist companies with the transition to MES systems so they can realise the benefits with minimal disruption to their operations.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance